LuPSMA moves UpFront | first RCT data with Arun Azad and Michael Hofman

[@BazAkladios]

Awesome work - congratulations

[@johnritson1]

Congratulations on a huge result!

[@fredfancy9199]

Awesome keep up

[@nyc863]

does this mean most (70%+) of men with high volume castrate sensitive prostate cancer who go onto ADT+chemo (common to both arms) failed to suppress PSA by the end of the year? implying that most of the arm that did not include LuPSMA went castrate resistant by the end of the year? or was psa in both arms dropping, just not as fast on average in the control arm?

[@gu_cast]

Good question @nyc863. The primary endpoint was undetectable PSA (